Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Cerevel Therapeutics Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common stock, par value $0.0001 per share

Other

76,781,567 (1)

$23.32(2)

$1,790,546,142.44 (2)

0.0000927

$165,983.63

Fees Previously Paid

Carry Forward Securities

Carry Forward Securities

Total Offering Amounts

$1,790,546,142.44

$165,983.63

Total Fees Previously Paid

$0.00

Total Fee Offsets

$0.00

Net Fee Due

$165,983.63

(1) Consists of 76,781,567 shares of the common stock of Cerevel Therapeutics Holdings, Inc., par value $0.0001 per share, or the Common Stock, to be offered by the selling stockholders named in the registration statement to which this exhibit relates, or the Registration Statement. In accordance with Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registration Statement also covers an indeterminate number of additional shares of common stock that may be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(2) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Common Stock as reported on the Nasdaq Capital Market on May 9, 2022, which was $23.32.